MENU

Advanced 3D cell models for cancer biology using real time live-cell analysis

Speaker
  • Principal R&D Scientist, Essen BioScience
    Biography
      Kalpana is currently a Principal Scientists within our UK Biology R&D team based at Essen BioSciences European laboratories. A highly experienced industrial pharmacologist with over 20 years of experience gained from pharmaceutical (GlaxoSmithKline) and contract research (BioFocus and Argenta) laboratories. A track record in applied drug discovery, latterly leading and influencing discovery programme teams. Trained initially as an in vitro pharmacologist, Kalpana went on to focus in the field of G-protein coupled receptor drug discovery and specialise in designing and developing plate-based cellular assays to support automated High Throughput Screening and Compound Profiling activities as well as generating mechanism of action follow-up assays. Kalpana joined Essen in 2011, applying her extensive expertise to leading R&D projects developing cellular assays for quantitative live cell analysis.

    Abstract

    Integrated protocols and live-cell analysis solutions for different 3D tumor models

    In the search for greater clinical translation, cancer researchers are increasingly turning to more complex live-cell assay systems that recapitulate key aspects of the tumor microenvironment. These include (1) more relevant tissue organization, (2) bio-matrices containing structural proteins and growth factors, and (3) the presence of stromal and immune cells. In this webinar, we describe integrated protocols and live-cell analysis solutions for different 3D tumor models, ranging from simple mono-culture single spheroid assays through to multi-spheroid tumor/fibroblast and tumor/immune cell co-cultures in a Matrigel biomatrix.

    You will learn how to:

    • Assemble 96-well 3D spheroid assays in both round-bottom ultra-low attachment microplates, and flat plates on a Matrigel base
    • Automatically acquire and analyse images over time, using the new IncuCyte S3 DF Brightfield modality and Spheroid module
    • Quantify tumor growth, morphology and viability, either label-free or with fluorescent cell health markers
    • Study the impact of stromal cells and immune cells on tumor biology in these 3D systems
    • Gain greater biological insight and productivity in your 3D tumor assays

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...

    Advanced 3D cell models for cancer biology using real time live-cell analysis


    No demographic data is available yet for this event.


    Show Resources
    Loading Comments...
    Show Resources